Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Preterm Births and PROM Testing Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Growing Incidence of Preterm and Low-weight Births
3.2.1.2. Rising Awareness and Technological Advancements in Point-Of Care and PROM Testing
3.2.2. Restraints
3.2.2.1. Lack of Awareness and Economic Constraints in Under-developed Countries
3.2.3. Opportunities
3.2.3.1. Advancements in Technology
3.2.4. Challenges
3.2.4.1. High cost and unmet needs
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Preterm Births and PROM Testing Market Overview
4.1. Market Size & Forecast, 2019-2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Test Type
4.2.1.1. Pelvic Exam
4.2.1.2. Ultrasound
4.2.1.3. Biochemical Markers
4.2.1.4. Uterine Monitoring
4.2.1.5. Nitazine Test
4.2.1.6. Ferning Test
4.2.1.7. Pooling
4.2.2. By End User
4.2.2.1. Hospitals
4.2.2.2. Clinical Laboratories
4.2.2.3. Others
4.2.3. By Region
4.2.3.1. North America
4.2.3.2. Europe
4.2.3.3. Asia Pacific (APAC)
4.2.3.4. Latin America (LATAM)
4.2.3.5. Middle East and Africa (MEA)
5. North America Preterm Births and PROM Testing Market
5.1. Market Size & Forecast, 2019-2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Test Type
5.2.2. By End User
5.2.3. By Country
5.2.3.1. United States
5.2.3.1.1. By Test Type
5.2.3.1.2. By End User
5.2.3.2. Canada
5.2.3.2.1. By Test Type
5.2.3.2.2. By End User
6. Europe Preterm Births and PROM Testing Market
6.1. Market Size & Forecast, 2019-2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By End User
6.2.3. By Country
6.2.3.1. Germany
6.2.3.1.1. By Test Type
6.2.3.1.2. By End User
6.2.3.2. United Kingdom
6.2.3.2.1. By Test Type
6.2.3.2.2. By End User
6.2.3.3. Italy
6.2.3.3.1. By Test Type
6.2.3.3.2. By End User
6.2.3.4. France
6.2.3.4.1. By Test Type
6.2.3.4.2. By End User
6.2.3.5. Spain
6.2.3.5.1. By Test Type
6.2.3.5.2. By End User
6.2.3.6. Belgium
6.2.3.6.1. By Test Type
6.2.3.6.2. By End User
6.2.3.7. Russia
6.2.3.7.1. By Test Type
6.2.3.7.2. By End User
6.2.3.7.3.
6.2.3.8. The Netherlands
6.2.3.8.1. By Test Type
6.2.3.8.2. By End User
6.2.3.9. Rest of Europe
6.2.3.9.1. By Test Type
6.2.3.9.2. By End User
7. Asia-Pacific Preterm Births and PROM Testing Market
7.1. Market Size & Forecast, 2019-2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By End User
7.2.3. By Country
7.2.3.1. China
7.2.3.1.1. By Test Type
7.2.3.1.2. By End User
7.2.3.2. India
7.2.3.2.1. By Test Type
7.2.3.2.2. By End User
7.2.3.3. Japan
7.2.3.3.1. By Test Type
7.2.3.3.2. By End User
7.2.3.4. South Korea
7.2.3.4.1. By Test Type
7.2.3.4.2. By End User
7.2.3.5. Australia & New Zealand
7.2.3.5.1. By Test Type
7.2.3.5.2. By End User
7.2.3.6. Indonesia
7.2.3.6.1. By Test Type
7.2.3.6.2. By End User
7.2.3.7. Malaysia
7.2.3.7.1. By Test Type
7.2.3.7.2. By End User
7.2.3.8. Singapore
7.2.3.8.1. By Test Type
7.2.3.8.2. By End User
7.2.3.9. Vietnam
7.2.3.9.1. By Test Type
7.2.3.9.2. By End User
7.2.3.10. Rest of APAC
7.2.3.10.1. By Test Type
7.2.3.10.2. By End User
8. Latin America Preterm Births and PROM Testing Market
8.1. Market Size & Forecast, 2019-2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By End User
8.2.3. By Country
8.2.3.1. Brazil
8.2.3.1.1. By Test Type
8.2.3.1.2. By End User
8.2.3.2. Mexico
8.2.3.2.1. By Test Type
8.2.3.2.2. By End User
8.2.3.3. Argentina
8.2.3.3.1. By Test Type
8.2.3.3.2. By End User
8.2.3.4. Peru
8.2.3.4.1. By Test Type
8.2.3.4.2. By End User
8.2.3.5. Rest of LATAM
8.2.3.5.1. By Test Type
8.2.3.5.2. By End User
9. Middle East & Africa Preterm Births and PROM Testing Market
9.1. Market Size & Forecast, 2019-2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By End User
9.2.3. By Country
9.2.3.1. Saudi Arabia
9.2.3.1.1. By Test Type
9.2.3.1.2. By End User
9.2.3.2. UAE
9.2.3.2.1. By Test Type
9.2.3.2.2. By End User
9.2.3.3. Qatar
9.2.3.3.1. By Test Type
9.2.3.3.2. By End User
9.2.3.4. Kuwait
9.2.3.4.1. By Test Type
9.2.3.4.2. By End User
9.2.3.5. South Africa
9.2.3.5.1. By Test Type
9.2.3.5.2. By End User
9.2.3.6. Nigeria
9.2.3.6.1. By Test Type
9.2.3.6.2. By End User
9.2.3.7. Algeria
9.2.3.7.1. By Test Type
9.2.3.7.2. By End User
9.2.3.8. Rest of MEA
9.2.3.8.1. By Test Type
9.2.3.8.2. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Preterm Births and PROM Testing Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Preterm Births and PROM Testing Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Hologic, Inc
12.2. Abbott
12.3. Sera Prognostics Inc.
12.4. Cooper Surgical Inc.
12.5. IQ Products
12.6. Qiagen N.V.
12.7. Biosynex
12.8. LifeCell International Pvt. Ltd.
12.9. Clinical Innovations, Inc.
12.10. NX Prenatal, Inc.
12.11. Medixibiochemica
12.12. Medtronic
12.13. Fisher & Paykel Healthcare Limited
12.14. FUJIFILM Holdings Corporation
12.15. Nonin
12.16. Getinge AB
12.17. General Electric
12.18. Koninklijke Philips N.V.
12.19. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research?
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations